Correlation Between Forte Biosciences and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and AN2 Therapeutics, you can compare the effects of market volatilities on Forte Biosciences and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and AN2 Therapeutics.
Diversification Opportunities for Forte Biosciences and AN2 Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Forte and AN2 is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Forte Biosciences and AN2 Therapeutics
Given the investment horizon of 90 days Forte Biosciences is expected to generate 4.81 times more return on investment than AN2 Therapeutics. However, Forte Biosciences is 4.81 times more volatile than AN2 Therapeutics. It trades about 0.29 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.21 per unit of risk. If you would invest 462.00 in Forte Biosciences on August 29, 2024 and sell it today you would earn a total of 1,206 from holding Forte Biosciences or generate 261.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Forte Biosciences vs. AN2 Therapeutics
Performance |
| Timeline |
| Forte Biosciences |
| AN2 Therapeutics |
Forte Biosciences and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Forte Biosciences and AN2 Therapeutics
The main advantage of trading using opposite Forte Biosciences and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Forte Biosciences vs. Eliem Therapeutics | Forte Biosciences vs. Scpharmaceuticals | Forte Biosciences vs. Milestone Pharmaceuticals | Forte Biosciences vs. Seres Therapeutics |
| AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Scpharmaceuticals | AN2 Therapeutics vs. Milestone Pharmaceuticals | AN2 Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |